ISO 14698 (parts 1 and 2) has been in place since 1998. The document is applicable to a range of environments, although it has tended to be referred to by those involved with the manufacture of sterile pharmaceuticals. That said, in my experience, few institutions are using it and instead turn to EU GMP, the FDA aseptic processing guidance or to the USP. Moreover, the standard is in need of an update.
With
considerations about what a revised version of parts 1 and 2 might look like,
some national standards bodies are considering where a version of non-sterile
pharmaceutical manufacturing environments is needed.
ISO
have reserved a part 9 in the ISO 14698 series for this purpose. National
standards bodies are currently considering the need for such a document and, if
so needed, what the main contents should be.
Then
justification for such a document is, according to ISO:
“The
most critical consideration in facility design, equipment selection, cleaning,
validation, production operation and maintenance in the manufacture of
non-sterile healthcare products is the active avoidance of conditions that
would favour microbial proliferation. Avoidance of these conditions requires a
scientific understanding of facility and operational situations that favor
microbial presence and proliferation. This part of ISO 14698 will provide
principles and guidance for the assessment of microbial risk and will discuss
manufacturing validation requirements and the identification of control points
which can prevent or eliminate conditions that are favorable to the apperance
of microbial contamination.”
If
approved, the document would be known as:
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources